Sirolimus-eluting balloons (SEBs) represent a significant advancement in percutaneous coronary intervention (PCI), offering a leave nothing behind approach that may reduce the need for permanent stents and their associated complications. Despite promising results from European trials and recent U.S. FDA approvals for drug-coated balloons (DCBs), adoption in the U.S. remains limited due to narrow indications, reimbursement challenges, and lack of standardized protocols. This educational activity addresses these barriers by disseminating contemporary evidence and practical guidance on SEBs, including insights from pivotal trials such as SELUTION DeNovo and SELUTION4ISR.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
CME included with membership
| Member | Free |
| Non-Member | $19 |
| Fellow-In-Training | Free |
| Cardio Team Member | Free |
Collected from the provider’s public pages · source
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 1 credit
- MOC · Up to 1 point
- Commercial Support
-
ReleasedMay 12, 2026
-
Last day to claim creditMay 13, 2029 3 years left
-
Society for Cardiovascular Angiography and Interventions, The SCAI 2026 Sirolimus-Eluting Balloons in Coronary PCI: Key Insights from Recent Evidence
-
Society for Cardiovascular Angiography and Interventions, The Conversation in Interventional Cardiology: Drug-Coated Balloons for De Novo Non aorto-ostial and Coronary Bifurcation Lesions: A Systematic Review and Meta-analysis
-
Society for Cardiovascular Angiography and Interventions, The Technical Mastery: Guidance on Proper Imaging, Lesion Preparation, and Deployment for Coronary Drug-Coated Balloons. Part 2: Coronary DCBs in De Novo Lesions, Small Vessel, and Bifurcation: The European Experience
-
Medscape, LLC Keeping the Pace: The Evolving Role of Plaque-Guided Care in Symptomatic Coronary Artery Disease Management
-
American Heart Association State-of-the-Art Coronary Imaging & Hemodynamic Physiology
-
PRIME Education, Inc. (PRIME®) From Evidence to Practice: Individualizing P2Y12 Strategies in Recurrent MI Management
